title: Periocular abscess caused by Pseudallescheria boydii after a posterior subtenon injection of triamcinolone acetonide.
abstract: BACKGROUND
  A posterior subtenon injection of triamcinolone acetonide is an alternative to intravitreal injection in diabetic macular edema and is known to have fewer vision-threatening complications. Here, we report a case of periocular abscess following posterior subtenon injection of triamcinolone.
  
  
  METHODS
  A 62-year-old woman who had diabetic macular edema and disc neovascularization underwent a posterior subtenon injection of triamcinolone acetonide and panretinal laser photocoagulation. One month later a periocular abscess was noted in the inferotemporal area adjacent to the scleral wall. Pus was removed by fine-needle aspiration, and microbiologic cultures identified Pseudallescheria boydii. The patient was given systemic and subconjunctival treatment with itraconazole. However, conjunctival infection and anterior chamber inflammation worsened, and another posterior subtenon abscess was found.
  
  
  RESULTS
  Despite long-term systemic and topical itraconazole therapy, retinal detachment and vitreous opacity were shown on B-scan, and atrophic bulbi resulted.
  
  
  CONCLUSIONS
  Pseudallescheria boydii infection of the eye and orbit can result in a poor visual outcome. Prompt surgical debridement and drainage of the abscess, along with appropriate antifungal therapy based on susceptibility testing, must be mandatory.
authors.affiliation: Department of Ophthalmology, Anam Hospital, Korea University College of Medicine, 26-1 Anam-dong 5-ga, Sungbuk-gu, Seoul, 136-705, South Korea.
authors.forename: In Kyung
authors.initials: IK
authors.lastname: Oh
authors.forename: Sehyun
authors.initials: S
authors.lastname: Baek
authors.forename: Kuhl
authors.initials: K
authors.lastname: Huh
authors.forename: Jaeryung
authors.initials: J
authors.lastname: Oh
mesh_terms: D000038:Abscess / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D000935:Antifungal Agents / Q000627:therapeutic use; D003238:Connective Tissue / Q000187:drug effects; D003930:Diabetic Retinopathy / Q000188:drug therapy; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D017964:Itraconazole / Q000627:therapeutic use; D008269:Macular Edema / Q000188:drug therapy; D008875:Middle Aged; D008271:Mycetoma / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D009916:Orbital Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D011541:Pseudallescheria / Q000302:isolation & purification*; D014057:Tomography, X-Ray Computed; D014222:Triamcinolone Acetonide / Q000009:adverse effects*
chemical_list: D000935:Antifungal Agents; D005938:Glucocorticoids; D017964:Itraconazole; D014222:Triamcinolone Acetonide